Skip to content

Examining the Validity and Reliability of the Dresden Falls Questionnaire in Patients With Parkinson's Diagnosis Living in Turkey

Examining the Validity and Reliability of the Dresden Falls Questionnaire in Patients With Parkinson's Diagnosis Living in Turkey

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06630026
Acronym
DREFAQ
Enrollment
64
Registered
2024-10-08
Start date
2024-10-15
Completion date
2025-03-30
Last updated
2025-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Falls, Parkinson Disease, Scale Reliability Validity

Keywords

Parkinson disease, Falls, Scale reliability validity

Brief summary

The aim of this study is to adapt the Dresden Falls Questionnaire scale (DREFAQ) to Turkish society and to make its validity and reliability in Turkish. The DREFAQ) scale developed by Frank, Anika, et al assesses falls in patients with Parkinson. It has 5 questions. This study will be conducted with Parkinson patients. The patients will be sought to answer questionnaires during regular rehabilitation sessions. 50 participants will be included in the study. In order to evaluate the validity of the DREFAQ, the Modified Falls Efficacy Scale (MFES), which can evaluate the efficacy of falls and has been validated in Turkish, and the Parkinson's Disease Quality of Life (PDQOL) questionnaire, which can evaluate the quality of life and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.

Detailed description

The reliability and validity of the scale will begin with language equivalence and cultural adaptation. The scale will be translated from English to Turkish by two people who are fluent in Turkish and English. A single Turkish translation will be obtained from these two Turkish translations with a common opinion. The scale, which has been translated into Turkish, will be translated into English by two other people who are fluent in Turkish and English. The scale translated into English will be compared with the original. If the developer of the scale, Frank, Anika, et al approves the translation of the scale, participants will be recruited for the study. In the pre-trial phase, a reassessment will be conducted with 15 participants to test the intelligibility of the scale. Based on the results of the pre-test phase, the final version of DREFAQ will be able to be modified. The data of DREFAQ are collecting through face-to-face when the patients came to the rehabilitation center. 50 participants will be included in the study. In order to evaluate the validity of the DREFAQ, the Modified Falls Efficacy Scale (MFES), which can evaluate the efficacy of falls and has been validated in Turkish, and the Parkinson's Disease Quality of Life (PDQOL) questionnaire, which can evaluate the quality of life and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.

Interventions

OTHERThe aim of this study is to adapt the Dresden Falls Questionnaire scale (DREFAQ)scale to Turkish society in Parkinson patients and to make its validity and reliability in Turkish.

• The aim of this study is to adapt the Dresden Falls Questionnaire scale (DREFAQ)scale to Turkish society and to make its validity and reliability in Turkish. It has 5 questions. This study will be conducted with Parkinson patients. The patients will be sought to answer questionnaires during regular rehabilitation sessions.

Sponsors

Istanbul Medeniyet University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Individuals with a Hoehn & Yahr score between 1-4, * Individuals who can ambulate with or without assistive equipment, * Individuals with a Mini Mental State Examination score of \>24, * Individuals with a history of falling at least once in the last year,

Exclusion criteria

* communication or cognitive problems, * aphasia and speech disorders * unstable medical conditions

Design outcomes

Primary

MeasureTime frameDescription
FallsBaselineFalls will be assessed with the Dresden Falls Questionnaire scale (DREFAQ). DREFAQ consists of 5 items in total. Items 1 to 4 are scored from 0 to 3. The total score of the DREFAQ is calculated by summing the first 4 items (0-12). The location of the injury (from item 4) and the circumstances (item 5) are not used in the score calculation but provide additional qualitative information. Higher scores indicate a high risk of falling.
Falls EfficacyBaselineFalls efficacy will be assessed with the Modified Falls Efficacy Scale (MFES) scale. The MFES consists of 14 items in total. Items are scored from 0 (not sure of himself/herself) to 10 (totally confident). Total score is between 0-140. Lower scores indicate a high risk of falling.

Secondary

MeasureTime frameDescription
Health-Related Quality of Life (HRQoL)BaselineOuality of life will be assessed with the Parkinson's Disease Quality of Life (PDQOL) questionnaire. It consists of 8 questions in total. Items are scored 0 to 4. Total score is between 0-32. Higher scores indicate lower quality of life.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026